De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC

NCT06572514 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: immunotherapy：pembrolizumab；chemo：albumin-bound paclitaxel and cisplatin

Sponsor

Ruijin Hospital